Physician profile
James A Merrell
NPI 1134330434
$2,540.67
in general payments reported to CMS, 2019-2025
24 companies · $939 in 2025
The $939 reported for 2025 was more than what 78% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $125 · 2021: $96.58 · 2022: $403 · 2023: $310 · 2024: $547 · 2025: $939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,796.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $384.03 | 2021-2025 | |
| Hologic Sales and Service, LLC | $264.12 | 2024-2025 | Coolseal Generator |
| Regeneron Healthcare Solutions, INC. | $259.12 | 2019-2025 | Dupixent |
| Amgen INC. | $191.24 | 2024-2025 | Tavneos |
| Advanced Bionics, LLC | $169.70 | 2022 | |
| Glaxosmithkline, LLC. | $162.70 | 2024-2025 | Nucala |
| Kls-Martin L.P. | $142.72 | 2020-2025 | |
| Tactile Systems Technology INC | $142.72 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Stryker Corporation | $132.45 | 2019-2025 | Scopis Ent |
| Cochlear Americas | $119.27 | 2019-2022 | |
| Medtronic, INC. | $101.95 | 2023-2025 | Pteye Parathyroid Detection System, Propel |
| Abbvie INC. | $78.13 | 2025 | |
| Inspire Medical Systems, INC. | $59.60 | 2023 | Inspire |
| Allergan, INC. | $53.84 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $50.47 | 2021-2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $36.32 | 2020-2021 | |
| Aerin Medical INC. | $32.90 | 2023-2024 | |
| Organogenesis INC. | $32.27 | 2024-2025 | Affinity, Novachor |
| Olympus America INC. | $28.57 | 2021 | |
| Medtronic USA, INC. | $26.83 | 2020 | |
| Acclarent, INC | $23.23 | 2022 | |
| Smith+Nephew, INC. | $21.57 | 2025 | Tula |
| Livanova USA, INC. | $15.28 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $11.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Merrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.